Jefferies Group LLC Assembly Biosciences, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$14.57 - $23.96 $976,190 - $1.61 Million
-67,000 Closed
0 $0
Q1 2020

Nov 24, 2020
BUY
$10.27 - $21.23 $688,090 - $1.42 Million
67,000 New
67,000 $1.02 Million
Q1 2020

May 15, 2020
SELL
$10.27 - $21.23 $371,465 - $767,889
-36,170 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$8.36 - $23.81 $206,960 - $589,440
24,756 Added 216.89%
36,170 $740,000
Q3 2019

Nov 13, 2019
BUY
$9.83 - $14.82 $112,199 - $169,155
11,414 New
11,414 $112,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $743M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email